Evidence map›Paper›PMID 30121618›Full record

Trial reportBMJ open2018

Clinical and cost-effectiveness of one-session treatment (OST) versus multisession cognitive-behavioural therapy (CBT) for specific phobias in children: protocol for a non-inferiority randomised controlled trial.

Barry D Wright, Cindy Cooper, Alexander J Scott, Lucy Tindall, Shehzad Ali, Penny Bee, Katie Biggs, Trilby Breckman, Thompson E Davis Iii, Lina Gega and 7 more

Open access · goldAbstract readEquivalence TrialRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Barry D WrightChild Oriented Mental Health Intervention Centre, IT Centre, Innovation Way, York, UK.
Cindy CooperScHARR, The University of Sheffield, Sheffield, UK.
Alexander J ScottScHARR, The University of Sheffield, Sheffield, UK.ORCID 0000-0001-7426-7099
Lucy TindallChild Oriented Mental Health Intervention Centre, IT Centre, Innovation Way, York, UK.
Shehzad AliDepartment of Health Sciences & Hull York Medical School, University of York, York, UK.
Penny BeeDivision of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK.
Katie BiggsScHARR, The University of Sheffield, Sheffield, UK.
Trilby BreckmanTriumph Over Phobia (TOP UK), Bath, UK.
Thompson E Davis IiiPsychological Services Center, Louisiana State University, Baton Rouge, Louisiana, USA.
Lina GegaDepartment of Health Sciences & Hull York Medical School, University of York, York, UK.
Rebecca Julie HargateChild Oriented Mental Health Intervention Centre, IT Centre, Innovation Way, York, UK.
Ellen LeeScHARR, The University of Sheffield, Sheffield, UK.
Karina LovellDivision of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK.
David MarshallCentre for Reviews and Dissemination, University of York, York, UK.
Dean McMillanDepartment of Health Sciences & Hull York Medical School, University of York, York, UK.
M Dawn TeareScHARR, The University of Sheffield, Sheffield, UK.
Jonathan WilsonResearch and Development, Norfolk and Suffolk NHS Foundation Trust, Norwich, UK.
University of Sheffield · GBUniversity of York · GBUniversity of Manchester · GBLouisiana State University · USNorfolk and Suffolk NHS Foundation Trust · GB

Funding

Department of Health HTA/15/38/04
6 · The paper itself

Abstract

introductionSpecific phobias (intense, enduring fears of an object or situation that lead to avoidance and severe distress) are highly prevalent among children and young people. Cognitive-behavioural therapy (CBT) is a well-established, effective intervention, but it can be time consuming and costly because it is routinely delivered over multiple sessions during several months. Alternative methods of treating severe and debilitating phobias in children are needed, like one-session treatment (OST), to reduce time and cost, and to prevent therapeutic drift and help children recover quickly. Our study explores whether (1) outcomes with OST are 'no worse' than outcomes with multisession CBT, (2) OST is acceptable to children, their parents and the practitioners who use it and (3) OST offers good value for money to the National Health Service (NHS) and to society.

methodA pragmatic, non-inferiority, randomised controlled trial will compare OST with multisession CBT-based therapy on their clinical and cost-effectiveness. The primary clinical outcome is a standardised behavioural task of approaching the feared stimulus at 6 months postrandomisation. The outcomes for the within-trial cost-effectiveness analysis are quality-adjusted life years based on EQ-5D-Y, and individual-level costs based of the intervention and use of health and social service care. A nested qualitative evaluation will explore children's, parents' and practitioners' perceptions and experiences of OST. A total of 286 children, 7-16 years old, with DSM-IV diagnoses of specific phobia will be recruited via gatekeepers in the NHS, schools and voluntary youth services, and via public adverts. ETHICS AND DISSEMINATION: The trial received ethical approval from North East and York Research Ethics Committee (Reference: 17/NE/0012). Dissemination plans include publications in peer-reviewed journals, presentations in relevant research conferences, local research symposia and seminars for children and their families, and for professionals and service managers. TRIAL REGISTRATION NUMBER: ISRCTN19883421;Pre-results.

Indexed as

AdolescentChildClinical ProtocolsCognitive Behavioral TherapyCost-Benefit AnalysisFemaleHumansMalePhobic DisordersTreatment Outcomechildren and adolescentsexposure therapyone-session treatmentphobiarandomised controlled trial

Identifiers

PMID30121618
PMCPMC6104754
OpenAlexW2885286410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.